---
layout: page
title: proteomics
description: with AZHEROES
img: assets/img/12.jpg
importance: 1
category: work
related_publications: true
---

Past & current proteomics analyses with the AZHEROES are listed below:


<div class="row">
    <div class="col-sm mt-3 mt-md-0">
        {% include figure.liquid loading="eager" path="assets/img/1.jpg" title="example image" class="img-fluid rounded z-depth-1" %}
    </div>
    <div class="col-sm mt-3 mt-md-0">
        {% include figure.liquid loading="eager" path="assets/img/3.jpg" title="example image" class="img-fluid rounded z-depth-1" %}
    </div>
    <div class="col-sm mt-3 mt-md-0">
        {% include figure.liquid loading="eager" path="assets/img/5.jpg" title="example image" class="img-fluid rounded z-depth-1" %}
    </div>
</div>
<div class="caption">
    Random photos.
</div>

- **Long COVID**: Understanding Long COVID (LC) in Frontline and Essential Workers (FEWs) through Proteomic Profiling: A Longitudinal Cohort Study
  - Led analytical team and developed statistical pipeline for proteomics analysis in AZHEROES
  - Processed and analyzed proteomics data from 130+ frontline and essential workers with COVID-19 infection to identify biomarkers associated with Long COVID
  - Applied bioinformatics techniques to map 20+ significant biological pathways
  - Lead author for a manuscript currently under internal review {% cite Liu_2026_2 %}

- **COVID Breakthrough**: Serum Proteomics in Omicron SARS-CoV-2 breakthrough: a nested case-control study within a prospective cohort of frontline workers from eight locations in the United States (US)
  - Assisted in proteomics analysis for 100+ breakthrough cases to identify risk factors for Omicron breakthrough
  - Contributed to a manuscript submitted to PLoS ONE {% cite Liu_2025_5 %}